P

Inventor

QUEROLLE OLIVIER ALEXIS GEORGES

FR33 patents
⚠️ This page may combine multiple inventors who share the name “QUEROLLE OLIVIER ALEXIS GEORGES”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

JANSSEN PHARMACEUTICA NV

21 patents
US11396517B1Jul 26, 2022

Exo-aza spiro inhibitors of menin-MLL interaction

JANSSEN PHARMACEUTICA NV6 citations71
US10611778B2Apr 7, 2020

Fused bicyclic inhibitors of menin-MLL interaction

JANSSEN PHARMACEUTICA NV3 citations71
US11530226B2Dec 20, 2022

Azepane inhibitors of menin-MLL interaction

JANSSEN PHARMACEUTICA NV1 citations60
US11220517B2Jan 11, 2022

Spiro bicyclic inhibitors of menin-MLL interaction

JANSSEN PHARMACEUTICA NV1 citations60
US10975100B2Apr 13, 2021

Fused bicyclic inhibitors of menin-MLL interaction

JANSSEN PHARMACEUTICA NV1 citations60
US10745409B2Aug 18, 2020

Azepane inhibitors of menin-MLL interaction

JANSSEN PHARMACEUTICA NV1 citations60
US11267804B2Mar 8, 2022

(R)-8-(1-((3-fluorophenyl)amino)ethyl)-N-(2-hydroxyethyl)-2-morpholinoquinoxaline-6-carboxamide for inhibiting phosphoinositide-3-kinase activity

JANSSEN PHARMACEUTICA NV0 citations59
US12473295B2Nov 18, 2025

Substituted straight chain spiro derivatives

JANSSEN PHARMACEUTICA NV0 citations54
US12084462B2Sep 10, 2024

Spiro bicyclic inhibitors of menin-MLL interaction

JANSSEN PHARMACEUTICA NV0 citations50
US11236084B2Feb 1, 2022

Substituted azaindoline derivatives as NIK inhibitors

JANSSEN PHARMACEUTICA NV0 citations50
US11186589B2Nov 30, 2021

Cyanoindoline derivatives as NIK inhibitors

JANSSEN PHARMACEUTICA NV0 citations50
US11180487B2Nov 23, 2021

Substituted cyanoindoline derivatives as NIK inhibitors

JANSSEN PHARMACEUTICA NV0 citations50
US11136311B2Oct 5, 2021

Heteroaromatic derivatives as NIK inhibitors

JANSSEN PHARMACEUTICA NV0 citations50
US11001569B2May 11, 2021

6-membered heteroaromatic substituted cyanoindoline derivatives as NIK inhibitors

JANSSEN PHARMACEUTICA NV0 citations50
US10526316B2Jan 7, 2020

Quinoxaline and pyridopyrazine derivatives as PI3Kβ inhibitors

JANSSEN PHARMACEUTICA NV0 citations49
US10894793B2Jan 19, 2021

Bicyclic pyridine, pyrazine, and pyrimidine derivatives as PI3K beta inhibitors

JANSSEN PHARMACEUTICA NV0 citations48
US11542247B2Jan 3, 2023

Bi-heteroaryl substitute 1,4-benzodiazepines and uses thereof for the treatment of cancer

JANSSEN PHARMACEUTICA NV0 citations47
US11130751B2Sep 28, 2021

Quinoxaline and pyridopyrazine derivatives as PI3K-beta inhibitors

JANSSEN PHARMACEUTICA NV0 citations47
US11155555B2Oct 26, 2021

Compounds

JANSSEN PHARMACEUTICA NV0 citations45
US10202387B2Feb 12, 2019

Heterocyclyl linked imidazopyridazine derivatives as PI3KB inhibitors

JANSSEN PHARMACEUTICA NV0 citations39
US10087187B2Oct 2, 2018

Imidazopyridazine derivatives as PI3KB inhibitors

JANSSEN PHARMACEUTICA NV0 citations39

ASTEX THERAPEUTICS LTD

12 patents